Koios DS™ Breast is revolutionizing breast cancer diagnostics with AI-powered ultrasound technology. Integrated seamlessly with PACS workstations, it provides quick and reliable malignancy risk assessments based on vast proprietary data.
Koios DS™ Breast is an FDA-cleared and CE-marked Smart Ultrasound® software that utilizes AI for early and accurate breast cancer diagnosis. Developed by Koios Medical, this cutting-edge solution has been built on more than 2 million proprietary ultrasound images and 17k feature analyses per image. This AI-powered system integrates seamlessly into most PACS workstations and offers a transformative approach to malignancy risk assessment in real-time.
The software is intended for the diagnosis of breast cancer using ultrasound technology.
Koios DS™ Breast is essential for radiologists, oncologists, and medical imaging facilities focused on enhancing breast cancer diagnosis and treatment strategies.
Automatic capture of all nodule descriptors, including dynamic BI-RADS or ATA calculations.
FDA-Cleared, CE Marked.
Established in 2007, Koios Medical initially used radar technology and machine learning for defense applications before pivoting to medical imaging. Over 12 years, the company has amassed a dataset of more than 500,000 ultrasound images tied to pathology results or at least a 1-year follow-up. Koios is committed to ongoing product development and improvement, quality system planning, and regulatory compliance as part of its effective quality management system (QMS).
by ClariPi Inc.
The ClariSIGMAM is an innovative breast cancer prediction marker. It is a breast
by MICA AI Medical
An AI-driven solution designed for dense breast mammography. Pioneering in CEM,
Let’s collaborate to harness the transformative power of these advanced technologies, propelling your medical practice to unprecedented levels of diagnostic accuracy, efficiency, and patient care.
Redeem your demo!
